VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3816
-0.0313 (-7.58%)
Oct 10, 2025, 12:14 PM EDT - Market open

VYNE Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
105032955273
Upgrade
Market Cap Growth
-64.18%54.55%268.63%-84.04%-79.99%61.32%
Upgrade
Enterprise Value
-29.1-11.84-61.01-21.9812.4248.49
Upgrade
Last Close Price
0.383.352.282.7018.36113.76
Upgrade
PE Ratio
--3.60-0.82-0.25-0.720.80
Upgrade
PS Ratio
37.0099.1675.8118.2858.7013.01
Upgrade
PB Ratio
0.210.950.360.281.127.28
Upgrade
P/TBV Ratio
0.422.740.260.271.085.47
Upgrade
P/FCF Ratio
--1.46-1.27-0.30-0.97-1.99
Upgrade
P/OCF Ratio
--1.46-1.27-0.30-0.97-1.99
Upgrade
EV/Sales Ratio
--23.62-143.89-46.0713.3211.84
Upgrade
EV/EBITDA Ratio
-0.272.090.64-0.32-0.99
Upgrade
EV/EBIT Ratio
-0.272.090.64-0.32-0.98
Upgrade
EV/FCF Ratio
-0.352.410.75-0.22-1.81
Upgrade
Debt / Equity Ratio
000.00000.91
Upgrade
Debt / EBITDA Ratio
0.000.00-0.01--0.01-0.14
Upgrade
Debt / FCF Ratio
0.000.00-0.01--0.01-0.25
Upgrade
Asset Turnover
0.010.010.010.010.010.24
Upgrade
Inventory Turnover
----00.32
Upgrade
Quick Ratio
6.794.1512.373.845.083.42
Upgrade
Current Ratio
7.604.3512.734.106.444.01
Upgrade
Return on Equity (ROE)
-84.69%-56.54%-46.48%-85.03%-102.66%-936.25%
Upgrade
Return on Assets (ROA)
-76.34%-53.03%-42.27%-63.65%-47.75%-288.50%
Upgrade
Return on Capital (ROIC)
-497.42%-456.79%-456.44%-309.19%-187.14%-943.08%
Upgrade
Return on Capital Employed (ROCE)
-93.66%-61.36%-48.14%-77.38%-60.23%-407.96%
Upgrade
Earnings Yield
-366.49%-27.76%-121.93%-394.44%-139.65%124.68%
Upgrade
FCF Yield
-379.27%-68.62%-78.83%-334.85%-103.14%-50.24%
Upgrade
Buyback Yield / Dilution
0.78%0.28%-257.44%-16.54%-139.45%-22.64%
Upgrade
Total Shareholder Return
-0.28%-257.44%-16.54%-139.45%-22.64%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q